These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5573186)

  • 21. [Prevention of experimental arthritis with the cytostatic agent podophyllinic acid ethylhydrazide].
    Szántó L; Lörincz G; Gömör B
    Arzneimittelforschung; 1968 Jul; 18(7):886-9. PubMed ID: 5756046
    [No Abstract]   [Full Text] [Related]  

  • 22. [Considerations on the use of Proresid (SPI-SPG Sandoz) as an adjuvant in the treatment of tumors (preliminart communication)].
    Motti VJ
    Hospital (Rio J); 1968 Oct; 74(4):1377-88. PubMed ID: 5304166
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of immunosuppressive therapy with podophyllin derivatives in the treatment of primary chronic polyarthritis].
    Szántó L
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:154. PubMed ID: 5402573
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cytostatic therapy of metastatic and advanced malignant tumors of the ENT region with podophyllin derivatives (SPI-SPG)].
    Lipozencić M; Padovan I
    Rad Med Fak Zagrebu; 1965; 13(1):57-67. PubMed ID: 5871944
    [No Abstract]   [Full Text] [Related]  

  • 25. [Combines cytostatic treatment of malignant tumors. (Clinical histological report of 4 cases)].
    Busch W; Goldschmidt F
    Krebsarzt; 1967; 22(4):224-33. PubMed ID: 5592995
    [No Abstract]   [Full Text] [Related]  

  • 26. [Submicroscopic changes in human cancer cells under the effect of SP-I and SP-G "Sandoz"].
    Sipus N; Padovan I; Lipozencić M
    Oncology; 1966; 20(4):276-90. PubMed ID: 5958475
    [No Abstract]   [Full Text] [Related]  

  • 27. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
    Chlud K; Prohaska E; Pfaller C
    Z Rheumaforsch; 1967 Jun; 26(5):250-60. PubMed ID: 4878333
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term chemotherapy for cancer of the lung.
    Anderson JM; Hutchison J
    Dis Chest; 1968 May; 53(5):551-9. PubMed ID: 4968890
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies of chemical sensitization in the radiotherapy of oral and cervical carcinomas.
    Krishnamurthi S; Shanta V; Nair MK
    Cancer; 1967 May; 20(5):822-5. PubMed ID: 5337396
    [No Abstract]   [Full Text] [Related]  

  • 31. Human anticancer effect of podophyllum derivatives (SPG and SPI): a preliminary report.
    Chakravorty RC; Sarkar SK; Sen S; Mukerji B
    Br J Cancer; 1967 Mar; 21(1):33-9. PubMed ID: 6024514
    [No Abstract]   [Full Text] [Related]  

  • 32. [The association of podophyllum derivatives and cyclophosphamide in the palliative therapy of female pelvic neoplasms].
    Varianti G
    Cancro; 1965; 18(6):526-41. PubMed ID: 4162232
    [No Abstract]   [Full Text] [Related]  

  • 33. [Synergic action of x-rays and of the ethylhydrazide of podophyllinic acid on a solid isologous tumor of the C3H mouse].
    Donner M; Oth D; Du Cluzel O; Burg C
    C R Seances Soc Biol Fil; 1967 Jul; 161(2):403-7. PubMed ID: 4229149
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical use of podophyllinic acid ethylhydrazide (SP-I) and podophyllotoxin-beta-o-benzyliden-glucoside (SP-G) in malignant urologic tumors].
    Aso Y; Hoshi Y; Okada K; Koiso K; Murahashi I
    Gan No Rinsho; 1969 May; 15(5):453-7. PubMed ID: 5387577
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experiences with SP-I].
    Furue H; Koizumi H; Nishi I; Hattori T; Yokoyama T
    Gan No Rinsho; 1967 Sep; 13(9):658-62. PubMed ID: 5627165
    [No Abstract]   [Full Text] [Related]  

  • 36. [Favourable response of advanced ovarian cancer to treatment with a podophyllin derivative (SP-I and SP-G)].
    Tomin R
    Srp Arh Celok Lek; 1965 Oct; 93(10):973-9. PubMed ID: 5872509
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cytostatic and antimetabolite therapy in chronic inflammatory joint diseases and collagen diseases].
    Chlud K
    Munch Med Wochenschr; 1969 Aug; 111(32):1626-9. PubMed ID: 5394967
    [No Abstract]   [Full Text] [Related]  

  • 38. [The treatment of primary chronic polyarthritis with immunosuppressive cytostatic podophyllin derivatives].
    Gömör B; Szántó L; Görgényi F; Benczur M; Ligetiné Reviczky A; Bányai B; Lörincz G
    Orv Hetil; 1969 Jan; 110(4):181-6. PubMed ID: 5779082
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemotherapy of stomatologic cancers].
    Szpirglas H; Jacquillat C; Brocheriou C; Crépy C; Cernéa P; Bernard J
    Rev Stomatol Chir Maxillofac; 1969; 70(5):387-402. PubMed ID: 5259528
    [No Abstract]   [Full Text] [Related]  

  • 40. [New possibilities in testing resistance of human carcinoma tissue to cytostatic agents in vivo].
    Heckmann U
    Dtsch Med Wochenschr; 1967 May; 92(20):932-5 passim. PubMed ID: 4960735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.